Endring i diagnostikk og behandling av hyperbilirubinemi hos nyfødte

Tidsskrift for den Norske Laegeforening

Volumn 130, Issue 1, 2010, Pages 18-20

  Tønne, Andreas ^a   Meberg, Alf ^a   Hager, Helle Borgstrøm ^b  

^a Barnesentere   (Norway)

^b VESTFOLD HOSPITAL TRUST   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD GROUP ABO SYSTEM; COHORT ANALYSIS; EXCHANGE BLOOD TRANSFUSION; HUMAN; IMMUNIZATION; IMMUNOLOGY; MASS SCREENING; NEWBORN; NEWBORN JAUNDICE; NORWAY; PHOTOTHERAPY; PRACTICE GUIDELINE; PROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; COHORT STUDIES; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; IMMUNIZATION; INFANT, NEWBORN; MASS SCREENING; NORWAY; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES;

EID: 77449122055     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.08.0035     Document Type: Article

References (25)

1. Bjerre JV, Ebbesen F. Genoptræden af kernikterus hos nyfødte børn i Danmark. Ugeskr Læger 2006; 168: 686-91.
2. Kernicterus in full-term infants - United States, 1994-1998. MMWR Morb Mortal Wkly Rep 2001; 50: 491-4.
3. Manning DJ, Maxwell MJ, Todd PJ et al. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92: F342-6.
4. Maisels JM, Newmann TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995; 96: 730-3.
5. Dodd KL. Neonatal jaundice - a lighter touch. Arch Dis Child 1993; 68: 529-33.
6. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the collaborative perinatal project. Pediatrics 1993; 92: 651-7.
7. Newman TB, Maisels JM. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89: 809-18.
8. Newman TB, Liljestrand P, Jeremy RJ et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006; 354: 1889-900.
9. Volpe JJ. Bilirubin and brain injury. I: Volpe JJ, red. Neurology of the newborn. Philadelphia: WB Saunders, 2001: 521-46.
10. Bratlid D. Fototerapi ved neonatal hyperbilirubinemi. Tidsskr Nor Lægeforen 1986; 106: 1830-3.
11. Finlay HVL, Tucker SM. Neonatal plasma bilirubin chart. Arch Dis Child 1978; 53: 90-1.
12. Subgruppen i nyfødtmedisin, Norsk Barnelegeforening. Norsk veileder for behandling av gulsott hos nyfødte. Oslo: Norsk Barnelegeforening, 2006.
13. Veileder for transfusjonstjenesten i Norge. 5. utgave. Oslo: Sosial- og helsedirektoratet, 2006.
14. Meberg A, Johansen KB. Screening for neonatal hyperbilirubinemia and ABO alloimmunization at the time of testing for phenylketonuria and congentital hypothyreosis. Acta Paediatr 1998; 87: 1269-74.
15. Bjerre JV, Petersen JR, Ebbesen F. Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr 2008; 97: 1030-4.
16. Burke BL, Robbins JM, Bird TM et al. Trends in hospitalizations for the neonatale jaundice and kernicterus in the United States, 1988-2005. Pediatrics 2009; 123: 524-32.
17. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994; 94 (4 pt 1): 558-65.
18. Huizing KM, Røislien J, Hansen TW. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility. Acta Paediatr 2008; 97: 1362-5.
19. Urbaniak SJ. ADCC (K cell) lysis of human erythrocytes sensitized with Rhesus alloantibodies. II. Investigation into mechanism of lysis. Br J Haematol 1979; 42: 315-28.
20. Bakkeheim E, Bergerud U, Schmidt-Melbye A-C et al. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate. Acta Paediatrica 2009; 98: 1896-1901.
21. Heier HE, Fugelseth D, Lindemann R et al. Blodtype O hos mor som risikofaktor for behandlingstrengende hyperbilirubinemi hos nyfødte. Tidsskr Nor Lægeforen 1996; 116: 34-6.
22. Han P, Kiruba R, Ong R et al. Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population. Aust Paediatr J 1988; 24: 35-8.
23. Lee K-S, Perlman M, Ballantyne M et al. Association between duration of neonatal hospital stay and readmission. J Pediatr 1995; 127: 758-66.
24. Hansen TW. Behandling av gulsott hos nyfødte. Tidsskr Nor Lægeforen 2005; 125: 594-8.
25. Meberg A, Wefring KW. Non-invasiv måling av serumbilirubin hos nyfødte. Tidsskr Nor Lægeforen 1984; 104: 970-2.